1. Performance evaluation of drug synergy datasets using computational intelligence approaches
   Pooja Rani et al, 2024, Multimedia Tools and Applications CrossRef
2. A Comprehensive Review on Deep Synergistic Drug Prediction Techniques for Cancer
   Vijay Kumar et al, 2022, Archives of Computational Methods in Engineering CrossRef
3. MFmap: A semi-supervised generative model matching cell lines to tumours and cancer subtypes
   Xiaoxiao Zhang et al, 2021, PLOS ONE CrossRef
4. MERAV: a tool for comparing gene expression across human tissues and cell types
   Yoav D. Shaul et al, 2016, Nucleic Acids Research CrossRef
5. WITHDRAWN: Detection and impact of hypoxic regions in multicellular tumor spheroid cultures formed by head and neck squamous cell carcinoma cells lines
   David A. Close et al, 2023, SLAS Discovery CrossRef
6. New Functional Signatures for Understanding Melanoma Biology from Tumor Cell Lineage-Specific Analysis
   Florian Rambow et al, 2015, Cell Reports CrossRef
7. Integrated analysis identified core signal pathways and hypoxic characteristics of human glioblastoma
   Yixing Gao et al, 2019, Journal of Cellular and Molecular Medicine CrossRef
8. Molecular subtyping of cancer: current status and moving toward clinical applications
   Lan Zhao et al, 2019, Briefings in Bioinformatics CrossRef
9. An efficient drug synergy model based on deep learning for malignant diseases
   Pooja Rani et al, 2023, 2023 International Conference on Computer, Electronics & Electrical Engineering & their Applications (IC2E3) CrossRef
10. Differential regulation and synthetic lethality of exclusive RB1 and CDKN2A mutations in lung cancer
    NAYOUNG KIM et al, 2016, International Journal of Oncology CrossRef
11. System analysis of the regulation of the immune response by CD147 and FOXC1 in cancer cell lines
    Yu-Kui Shang et al, 2018, Oncotarget CrossRef
12. High Content Screening Characterization of Head and Neck Squamous Cell Carcinoma Multicellular Tumor Spheroid Cultures Generated in 384-Well Ultra-Low Attachment Plates to Screen for Better Cancer Drug Leads
    Stanton J. Kochanek et al, 2019, ASSAY and Drug Development Technologies CrossRef
13. Lung Cancer Computational Biology and Resources
    Ling Cai et al, 2022, Cold Spring Harbor Perspectives in Medicine CrossRef
14. Prediction of Clinical Drug Response Based on Differential Gene Expression Levels
    Zhenyu Yue et al, 2015, Intelligent Computing Theories and Methodologies CrossRef
15. High-Content Screening Comparison of Cancer Drug Accumulation and Distribution in Two-Dimensional and Three-Dimensional Culture Models of Head and Neck Cancer
    Feng Shan et al, 2018, ASSAY and Drug Development Technologies CrossRef
16. Detection and impact of hypoxic regions in multicellular tumor spheroid cultures formed by head and neck squamous cell carcinoma cells lines
    David A. Close et al, 2022, SLAS Discovery CrossRef
17. Implementation of the NCI-60 Human Tumor Cell Line Panel to Screen 2260 Cancer Drug Combinations to Generate >3 Million Data Points Used to Populate a Large Matrix of Anti-Neoplastic Agent Combinations (ALMANAC) Database
    David A. Close et al, 2019, SLAS Discovery CrossRef
18. Automation of antimicrobial activity screening
    Samuel P. Forry et al, 2016, AMB Express CrossRef
19. Methods: for studying pharmacogenetic profiles of combination chemotherapeutic drugs
    Antonello Di Paolo et al, 2015, Expert Opinion on Drug Metabolism & Toxicology CrossRef